News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

Immunotherapy Continues to Show Promise in Treating Gastric Cancers

In the phase 1b JAVELIN trial, pretreated patients with gastric/gastroesophageal junction cancers (GC/GEJ) responded well to avelumab, a PD-L1 antibody.

 

X